Background The impact of precision psychiatry for clinical practice has not been
systematically appraised. This study aims to provide a comprehensive review of validated …

Background: Primary prevention has the potential to modify the course of depression, but the
consistency and magnitude of this effect are currently undetermined. Methods: PRISMA and …

The identification of generalizable treatment response classes (TRC [s]) in major depressive
disorder (MDD) would facilitate comparisons across studies and the development of …

The information on prevalence of obesity, diabetes, metabolic syndrome (MetS) and
cardiovascular risk (CVR) and on sociodemographic variables available in patients with …

Objective Major depressive disorder (MDD) is associated with increased amounts of intra-
abdominal and epicardial adipose tissue, risk factors for the development of cardio …

Many psychiatric patients suffer from overweight/obesity and subsequent metabolic
disturbances, where psychotropic medication is one of the main contributors. However, the …

Background Weight gain is a common side effect in psychopharmacology; however,
targeted therapeutic interventions and prevention strategies are currently absent in day‐to …

Introduction: Antipsychotic-induced weight gain (WG) and metabolic abnormalities are major
concerns. This review was untaken to answer if there is a weight-neutral second-generation …

Methadone maintenance treatment (MMT) is an important treatment tool for the opioid
epidemic. One challenge is that many persons who present for MMT also have co-occurring …

Значительная межинидивидуальная вариабельность факта формирования, спектра и
выраженности метаболических побочных эффектов при использовании атипичных …